Nippon Life Global Investors Americas Inc. increased its stake in CME Group Inc. (NASDAQ:CME) by 13.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 82,890 shares of the financial services provider’s stock after buying an additional 10,090 shares during the period. Nippon Life Global Investors Americas Inc.’s holdings in CME Group were worth $10,381,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. RMB Capital Management LLC raised its stake in CME Group by 3.1% in the first quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock valued at $13,642,000 after buying an additional 3,501 shares during the last quarter. Profund Advisors LLC raised its stake in CME Group by 4.2% in the first quarter. Profund Advisors LLC now owns 11,222 shares of the financial services provider’s stock valued at $1,333,000 after buying an additional 457 shares during the last quarter. Thrivent Financial For Lutherans raised its stake in CME Group by 5.6% in the first quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock valued at $1,485,000 after buying an additional 660 shares during the last quarter. Parsons Capital Management Inc. RI acquired a new stake in CME Group during the first quarter valued at about $569,000. Finally, Dowling & Yahnke LLC raised its stake in CME Group by 1.7% in the first quarter. Dowling & Yahnke LLC now owns 6,844 shares of the financial services provider’s stock valued at $813,000 after buying an additional 114 shares during the last quarter. Institutional investors own 83.29% of the company’s stock.

Shares of CME Group Inc. (CME) opened at 123.26 on Friday. The stock’s 50 day moving average is $123.41 and its 200-day moving average is $120.96. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96. The stock has a market capitalization of $41.90 billion, a price-to-earnings ratio of 25.16 and a beta of 0.73.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The firm had revenue of $925 million during the quarter, compared to analysts’ expectations of $931.05 million. During the same period in the previous year, the company earned $1.14 EPS. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, analysts expect that CME Group Inc. will post $4.81 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.66 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.14%. CME Group’s dividend payout ratio is presently 53.99%.

TRADEMARK VIOLATION WARNING: This news story was first posted by Daily Political and is the property of of Daily Political. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.dailypolitical.com/2017/08/13/nippon-life-global-investors-americas-inc-boosts-stake-in-cme-group-inc-nasdaqcme.html.

CME has been the subject of several analyst reports. Deutsche Bank AG upped their price target on shares of CME Group from $136.00 to $137.00 and gave the company a “buy” rating in a research report on Tuesday, April 18th. Citigroup Inc. initiated coverage on shares of CME Group in a research report on Wednesday, July 12th. They set a “buy” rating and a $140.00 price target for the company. Royal Bank Of Canada set a $130.00 price target on shares of CME Group and gave the company a “buy” rating in a research report on Monday, June 12th. UBS AG restated a “buy” rating and set a $134.00 price target (down from $136.00) on shares of CME Group in a research report on Monday, June 5th. Finally, Jefferies Group LLC restated a “buy” rating and set a $128.00 price target on shares of CME Group in a research report on Monday, July 10th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $131.63.

In related news, Director Martin J. Gepsman sold 200 shares of CME Group stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $126.14, for a total transaction of $25,228.00. Following the completion of the transaction, the director now directly owns 43,311 shares of the company’s stock, valued at approximately $5,463,249.54. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, President Bryan T. Durkin sold 9,200 shares of CME Group stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total transaction of $1,151,196.00. Following the transaction, the president now directly owns 70,938 shares of the company’s stock, valued at $8,876,471.94. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 91,085 shares of company stock valued at $11,242,896. 0.61% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.